Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and <i>Mycoplasma hyopneumoniae</i> When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection

Four studies under preclinical and clinical conditions were performed to evaluate the efficacy of a new trivalent vaccine against Porcine circovirus 2 (PCV-2) infection. The product contained inactivated PCV-1/PCV-2a (cPCV-2a) and PCV-1/PCV-2b (cPCV-2b) chimeras, plus <i>M. hyopneumoniae</i> inactiv...

Повний опис

Бібліографічні деталі

Автори:	Patricia Pleguezuelos, Marina Sibila, Raúl Cuadrado-Matías, Rosa López-Jiménez, Diego Pérez, Eva Huerta, Mónica Pérez, Florencia Correa-Fiz, José Carlos Mancera-Gracia, Lucas P. Taylor, Stasia Borowski, Gillian Saunders, Joaquim Segalés, Sergio López-Soria, Mònica Balasch
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2022-08-01
Серія:	Vaccines
Предмети:	swine porcine circovirus 2 porcine circovirus 2-systemic disease <i>Mycoplasma hyopneumoniae</i> porcine respiratory disease complex trivalent vaccine
Онлайн доступ:	https://www.mdpi.com/2076-393X/10/8/1234
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!